retatrutide ly3437943 glp-1 gip glucagon triple agonist (RETA) is one of the most promising investigational Retatrutide is the triple-agonist GLP-1

Weight loss is similar between drug classesnearly 2 kg (4 lb, 6 oz) with SGLT-2 inhibitors and 1.5 kg (3 lb, 5 oz) with GLP-1 receptor agonists

Plus, a gentle tingle from ginger and capsicum brings an instant plumping boostso your lips look pillowy, plush, and oh-so kissable (all while smelling like fresh melon and strawberry)

GLP1 RA Mechanisms of Action and Weight Loss As of January 2025, there are three incretin mimetic medications approved for treatment of overweight and obesity: liraglutide, semaglutide, and tirzepatide

She also encourages a metabolic-health workup to check for insulin resistance and other conditions like high cholesterol or hyperlipidemia

Ethical approval The study was approved by the Institutional Review Board for Clinical Research Committee (IRB) of Mansoura University with the approval code R.22.10.1897.R1 and with the IRB committee, Al Yousif Hospital, Alkhobar, Saudi Arabia, (AYH IRB: 02/03/2023)